Advisor Group Holdings »

Brainstorm Cell Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 1.8k 0.76
2025-06-30 $2.0k 1.8k 1.12
2025-03-31 $2.2k 1.7k 1.26
2024-12-31 $4.3k 1.9k 2.27

More positions owned by Advisor Group Holdings

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Spdr Series Trust Portfolio S&p500 (SPLG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Technology (XLK)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Advisor Group Holdings

Top funds holding Brainstorm Cell Therapeutics

Morgan Stanley
Advisor Group Holdings
Bangor Savings Bank
VSM Wealth Advisory
Steward Partners Investment Advisory
D. J. St. Germain

View all funds holding Brainstorm Cell Therapeutics